← All Amylyx Pharmaceuticals, INC filings

Amylyx Pharmaceuticals, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
AMLX
Amylyx Pharmaceuticals, INC
DEF: Amylyx Pharmaceuticals Schedules 2026 Annual Meeting
Amylyx Pharmaceuticals, Inc. has announced its 2026 Annual Meeting of Stockholders, to be held virtually on June 4, 2026, focusing on director elections, auditor ratification, and executive compensation.
NASDAQ
AMLX
Amylyx Pharmaceuticals, INC
DEFA14A: Amylyx Pharmaceuticals Sets Date for 2025 Annual Stockholder Meeting
Amylyx Pharmaceuticals will hold its annual stockholder meeting virtually on June 5, 2025, to vote on director elections, auditor ratification, and executive compensation.
NASDAQ
AMLX
Amylyx Pharmaceuticals, INC
DEF: Amylyx Pharmaceuticals Sets Date for 2025 Annual Stockholders Meeting
Amylyx Pharmaceuticals will hold its 2025 Annual Meeting of Stockholders virtually on June 5, 2025, to vote on director elections, ratification of the accounting firm, and executive compensation.
NASDAQ
AMLX
Amylyx Pharmaceuticals, INC
DEFA14A: Amylyx Pharmaceuticals Sets Date for 2024 Annual Stockholder Meeting
Amylyx Pharmaceuticals announces its annual stockholder meeting to be held virtually on June 6, 2024, with proxy materials available online.
NASDAQ
AMLX
Amylyx Pharmaceuticals, INC
DEF 14A: Amylyx Pharmaceuticals Sets Date for 2024 Annual Stockholders Meeting
Amylyx Pharmaceuticals will hold its 2024 Annual Meeting of Stockholders virtually on June 6, 2024, to vote on director elections, auditor ratification, executive compensation, and other matters.